Prostasin exosomes released into the blood during disease states, such as cardiovascular disease, diabetes, and cancers [2], or released from the epithelial cells into the immediate interstitial environments, are able to interact with TLR4 or PAR2, during immune-epithelial cell–cell interactions as a mechanism of immune modulation. The gene discussed is F2RL1; the disease is cancer.